You are here

asunaprevir

Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field

First Word Pharma

Tue, 10/7/14 - 08:48 am

Bristol-Myers Squibb

Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?

Motley Fool

Tue, 04/15/14 - 10:36 am

Gilead Sciences

Bristol-Myers Squibb

Encouraging Data from Bristol-Myers

Yahoo/Zacks

Sat, 04/12/14 - 10:20 am

Bristol-Myers Squibb

Bristol-Myers hepatitis C treatment cures up to 90 pct -study

Yahoo/Zacks.com

Thu, 04/10/14 - 07:35 am

Bristol-Myers Squibb

Bristol-Myers submits NDAs for Hep C drugs

Seeking Alpha

Mon, 04/7/14 - 09:57 am

Bristol-Myers Squibb

Bristol-Myers Squibb First to Japan in New Hepatitis C Therapy Race

Motley Fool

Wed, 11/6/13 - 10:27 am

Bristol-Myers Squibb

Bristol seeks Japan approval of all-oral hepatitis C treatment

Yahoo/Reuters

Sat, 11/2/13 - 11:56 am

Bristol-Myers Squibb

3 Companies Racing to Transform Hepatitis-C Treatment

Motley Fool

Thu, 09/19/13 - 02:58 am

Bristol-Myers Squibb

Three Future Winners and One Major Loser in the HCV Wars

Motley Fool

Fri, 07/19/13 - 11:38 am

Bristol-Myers Squibb

Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race

TheStreet.com

Tue, 04/23/13 - 11:21 am

Bristol-Myers Squibb

Bristol-Myers Hepatitis C Combo Therapy Blunts Disease

Bloomberg

Tue, 04/23/13 - 08:48 am

Bristol-Myers Squibb

Bristol-Myers Hepatitis C Combo Therapy Shows Promise

Bloomberg

Tue, 11/13/12 - 11:11 am

Bristol-Myers Squibb

Bristol-Myers' Daclatasvir, Asunaprevir Cured 77%: Study

Bloomberg

Thu, 04/19/12 - 01:03 pm

Bristol-Myers Squibb